RedHawk Partners With Pelican Engineering LLC for GMP Manufacturing Oversight
February 28, 2020 | PR NewswireEstimated reading time: 2 minutes
RedHawk Holdings Corp., a diversified holding company engaged in sales and distribution of medical devices, branded generic pharmaceutical drugs, commercial real estate investment and leasing, point of entry full-body security systems, and specialized financial services, announced today that RedHawk Research & Development LLC, a wholly-owned subsidiary of the Company, has agreed to partner with Louisiana-based Pelican Engineering LLC ("Pelican") for the supervision of the Company's quality assurance and future research and development programs.
Pelican is a full-service electronics engineering design firm that provides engineering services and component manufacturing in all aspects of the electrical, electronics, and computer engineering disciplines. Primarily focused on embedded printed circuit board hardware and software development, Pelican is capable of in-house engineering, design, manufacturing, and turn-key delivery of high-quality embedded systems.
Pelican was instrumental in the redesign of the SANDD Pro™ as well as the new printed circuit boards used in the SANDD mini – HP™ and the SANDD mini – FR™. Separately, Pelican is also expected to lead the development and redesign of "Centri", the Company's controlled entry security system, a unique, closed cabinet, nominal dose transmission full-body x-ray scanner.
In June 2019, the Company announced the transition and ongoing maintenance of its current FDA-approved quality management system to the higher and more stringent international medical device standard, ISO 13485:2016. The Company believes it is now near completion of this previously announced quality management transition and has now partnered with Pelican to develop and supervise the quality assurances testing believed necessary to maintain adherence to the stringent standards of ISO 13485:2016.
ISO 13485:2016 specifies global requirements for a quality management system where an organization must demonstrate its ability, and the ability of its suppliers, to provide medical devices and related services that consistently meet customer and applicable international regulatory requirements. ISO 13485 was specifically developed with the objective of harmonizing medical device regulatory requirements for quality management systems in major markets around the world including the United States, Europe, Canada, Japan and Australia. ISO 13485 meets, or exceeds, all U.S. Food and Drug Administration Quality System Regulations Standard 21 CFR 820 which was established in 1978 to outline Current Good Manufacturing Practices (GMP) in the United States.
Commenting on the partnership with Pelican, G. Darcy Klug, RedHawk's Chairman and Interim Chief Executive Officer, said "We believe the previously announced partnership with the CKRX Enterprise sales organization positions us well for the commercial launch of our SANDD™ line of needle incineration products.Our next marketing focus is the consumer launch of the SANDD™ line of needle incineration devices. To properly position RedHawk for the consumer market, we believe we need to obtain Durable Medical Equipment ("DME") Accreditation of our quality assurance program. The transition of our quality assurance program to ISO 13485:2016 and the completion of the quality assurance partnership with Pelican is the next step in preparing for DME Accreditation."
"DME Accreditation is necessary for RedHawk to obtain a DME supplier license," continued Mr. Klug. "With Pelican's support, we believe that we are now positioned to seek the necessary DME Accreditation approvals. With DME Accreditation, we anticipate our customers will be eligible to receive Medicare, Medicaid or insurance company reimbursement for the purchase of our SANDD™ line of needle incineration devices. Obtaining these approvals would be a major milestone on the path for RedHawk to continue executing on its business model."
Suggested Items
Lockheed Martin Successfully Transitions Long Range Discrimination Radar To The Missile Defense Agency
04/23/2024 | Lockheed MartinThe Long Range Discrimination Radar (LRDR) at Clear Space Force Station in Clear, Alaska, completed DD250 final acceptance and was officially handed over to the Missile Defense Agency in preparation for an Operational Capability Baseline (OCB) decision and final transition to the Warfighter. In addition, prior to this transition, the system has started Space Domain Awareness data collects for the United States Space Force.
US Department of Defense Selects Intel Foundry for Phase Three of RAMP-C
04/23/2024 | IntelThe U.S. Department of Defense (DoD) has awarded Intel Foundry Phase Three of its Rapid Assured Microelectronics Prototypes - Commercial (RAMP-C) program.
Real Time with... IPC APEX EXPO 2024: AI Implementation at Omron
04/18/2024 | Real Time with...IPC APEX EXPOEditor Nolan Johnson and Omron Product Manager Nick Fieldhouse discuss the company's focus on AI implementation to enhance customer experience and results. They address programming challenges and how AI can help customers achieve better outcomes with less experience. Omron's AI is compatible with existing systems, facilitating easy upgrades.
Cadence Unveils Palladium Z3 and Protium X3 Systems
04/18/2024 | Cadence Design SystemsThe Palladium Z3 and Protium X3 systems offer increased capacity, and scale from job sizes of 16 million gates up to 48 billion gates, so the largest SoCs can be tested as a whole rather than just partial models, ensuring proper functionality and performance.
Real Time with... IPC APEX EXPO 2024: MYCRONIC's Evolution and New Solutions
04/17/2024 | Real Time with...IPC APEX EXPOHenry Crandall interviews Kevin Clue, the vice president of global sales for MYCRONIC's High Flex division. They discuss the company's evolution, emphasizing its strong customer relationships and its role as a versatile, turnkey solution provider. Kevin unveils new solutions launched at IPC APEX EXPO, including an AI-integrated inspection system and the A40 pick-and-place platform. The conversation also touches on the increased use of AI and deep learning.